Skip to content
Menu

JP Morgan Maintains Overweight on Omada Health, Lowers Price Target to $25

Benzinga Newsdesk 4 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $30 to $25.

JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $30 to $25.

Read at benzinga.com